Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CN
$ 0.387
-10 %
$ 1.35 M
Market Cap
-0.11
P/E
BALANCE SHEET
23.1 M
ASSETS
9.2 M
LIABILITIES
13.9 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
China SXT Pharmaceuticals, Inc.
| Current Assets | 14.2 M |
| Cash & Short-Term Investments | 12.1 M |
| Receivables | 1.35 M |
| Other Current Assets | 810 K |
| Non-Current Assets | 8.89 M |
| Long-Term Investments | 0 |
| PP&E | 565 K |
| Other Non-Current Assets | 8.33 M |
| Current Liabilities | 8.9 M |
| Accounts Payable | 1.28 M |
| Short-Term Debt | 2.35 M |
| Other Current Liabilities | 5.27 M |
| Non-Current Liabilities | 295 K |
| Long-Term Debt | 295 K |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Cash & Cash Equivalents | 12.1 | 17.4 | 15.5 | 13.3 | 7.3 | 9.1 | 0.6 | 65.6 K | 11.4 K |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.3 | 1.3 | 4.9 | 7.8 | 10.6 | 4.9 | 3.9 | 3.8 | 4.1 |
| Inventory | 0.8 | 0.5 | 1.0 | 0.9 | 0.9 | 1.0 | 1.3 | 0.9 | 1.7 |
| Other Current Assets | 0 | 0.2 | 1.0 | 1.3 | 0.8 | 0.5 | 0.4 | 0.1 | 59.4 K |
| Total Current Assets | 14.2 | 19.5 | 22.5 | 23.2 | 19.6 | 15.6 | 6.1 | 4.9 | 5.8 |
| PP&E | 0.6 | 1.3 | 1.6 | 1.8 | 1.9 | 1.8 | 1.5 | 0.5 | 0.4 |
| Intangible Assets | 19.1 K | 27.9 K | 38.8 K | 45.8 K | 50.1 K | 61.1 K | 60.7 K | 41 K | 41.4 K |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | (0.4) | 13.5 K | 6.17 K | 0 | 0 |
| Other Long Term Assets | 8.3 | 8.7 | 9.5 | 9.2 | 0.4 | 13.5 K | 6.17 K | 0 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 23.1 | 29.6 | 33.5 | 34.5 | 21.7 | 17.5 | 7.7 | 5.4 | 6.3 |
| LIABILITIES | |||||||||
| Accounts Payable | 1.3 | 1.4 | 1.5 | 1.5 | 1.9 | 1.7 | 2.4 | 1.3 | 2.9 |
| Short Term Debt | 2.4 | 3.4 | 2.0 | 37.1 K | 6.7 | 0.2 | 0.4 | 0.3 | 0.5 |
| Other Current Liabilities | 4.0 | 8.5 | 12.3 | 15.7 | 2.4 | 3.3 | 0.7 | 1.7 | 1.6 |
| Total Current Liabilities | 8.9 | 14.5 | 17.1 | 18.6 | 12.3 | 6.3 | 4.4 | 3.6 | 5.6 |
| Long Term Debt | 0.3 | 0.4 | 0 | 6.29 K | 36.5 K | 41.7 K | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 9.2 | 14.9 | 17.1 | 18.6 | 12.3 | 6.4 | 4.4 | 3.6 | 5.6 |
| EQUITY | |||||||||
| Common Stock | 4.4 | 0.9 | 0.2 | 62.1 K | 34.7 K | 22.7 K | 20 K | 20 K | 20 K |
| Retained Earnings | (24.7) | (21.6) | (15.7) | (10.0) | (7.2) | 3.1 | 1.5 | 0.4 | (0.8) |
| Other Accumulative Comprehensive Income/Loss | (1.0) | (0.2) | 1.0 | 0.5 | (0.6) | 50.4 K | 0.3 | 11.8 K | 87.1 K |
| Total Equity | 13.9 | 14.7 | 16.4 | 16.0 | 9.4 | 11.1 | 3.3 | 1.9 | 0.7 |
| Total Liabilities and Equity | 23.1 | 29.6 | 33.5 | 34.5 | 21.7 | 17.5 | 7.7 | 5.4 | 6.3 |
| SHARES OUTSTANDING | |||||||||
| Common Shares Outstanding | 0.9 | 0.3 | 41.6 K | 28.8 K | 12.4 K | 10.3 K | 0 | 0 | 0 |